Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2026)
Raphael Pharmaceutical's Current Assets was $6,000 in Q2 2026, down 78.6% from $28,000 a year earlier.
Powered by 
Analysis
Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Raphael Pharmaceutical came in at $51,000, up 104.0% from FY2024.
- Current Assets shows a five-year compound annual growth rate of -30.9% (FY2020 to FY2025).
- In earlier years, Current Assets was $25,000 in FY2024 (-89.5%), $237,000 in FY2023 (-28.4%), $331,000 in FY2022 (-21.6%) and $422,000 in FY2021 (+30.7%).
- Quarterly Current Assets has moved between $5,000 (Q3 2025) and $422,000 (Q4 2021) over five years.
- Compared with a year earlier, Current Assets was higher in 1 of the last seven quarters, with an average decline of 56.2%.
- The best year-over-year quarter for Current Assets over five years was Q3 2023 (growth of 237.8%); the worst was Q3 2025 (a decline of 89.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.08 Bn | 1,101.67 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 616.40 Bn | 534.93 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 367.18 Bn | 321.56 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.67 Bn | 235.36 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 235.57 Bn | 190.97 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 190.62 Bn | 164.82 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Raphael Pharmaceutical | 30.47 Mn | 30.40 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 350,000.00 |
| Dec 31, 2023 | 237,000.00 |
| Sep 30, 2023 | 402,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Dec 31, 2022 | 331,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 196,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 422,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Dec 31, 2020 | 323,000.00 |
API Access
Raphael Pharmaceutical Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RAPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RAPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RAPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();